GR1000466B - Preparation method of novel pharmaceutical forms of cyclosporine - Google Patents
Preparation method of novel pharmaceutical forms of cyclosporineInfo
- Publication number
- GR1000466B GR1000466B GR900100076A GR900100076A GR1000466B GR 1000466 B GR1000466 B GR 1000466B GR 900100076 A GR900100076 A GR 900100076A GR 900100076 A GR900100076 A GR 900100076A GR 1000466 B GR1000466 B GR 1000466B
- Authority
- GR
- Greece
- Prior art keywords
- cyclosporine
- preparation
- pharmaceutical forms
- novel pharmaceutical
- alkylene
- Prior art date
Links
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title abstract 2
- 108010036949 Cyclosporine Proteins 0.000 title abstract 2
- 229960001265 ciclosporin Drugs 0.000 title abstract 2
- 229930182912 cyclosporin Natural products 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 4
- -1 fatty acid saccharide Chemical class 0.000 abstract 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 2
- 229920005862 polyol Polymers 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 abstract 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 229940057995 liquid paraffin Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920001515 polyalkylene glycol Polymers 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 150000003077 polyols Chemical class 0.000 abstract 1
Abstract
Φαρμακευτικές συνθέσεις οι οποίες περιλαμβάνουν (α) μια κυκλοσπορίνη ως δραστικό συστατικό (β) ένα μονοεστέρα σακχαρίτου λιπαρού οξέος και (γ) ένα αραιωτικό μέσο ή ένα φορέα. Τα συστατικά (γ) συνήθως είναι αιθανόλη, μια αλκυλενογλυκόλη (π.χ. 1,2-προπυλενογλυκόλη), μια αλκυλενοπολυόλη (π.χ. γλυκερίνη), μια πολυαλκυλενογλυκόλη (π.χ. FEG), ένας αλκυλενοπολυολοαιθήρ ή εστήρ (π.χ. προϊόν GELUCIR), υπερυγρά ή υπογρά παραφφίνη ένα πολυμερές οξειδίου οργανοσιλικόνης, ενώ ολιγώτερο προτιμάται η αιθανόλη.ωPharmaceutical compositions comprising (a) a cyclosporine as an active ingredient (b) a fatty acid saccharide monoester and (c) a diluent or carrier. Components (c) are usually ethanol, an alkylene glycol (e.g. 1,2-propylene glycol), an alkylene polyol (e.g. glycerin), a polyalkylene glycol (e.g. FEG), an alkylene polyol ether or ester (e.g. e.g. GELUCIR product), ultra-liquid or sub-liquid paraffin an organosilicon oxide polymer, while ethanol is less preferred.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898901898A GB8901898D0 (en) | 1989-01-28 | 1989-01-28 | Cane protection caps |
| GB898902898A GB8902898D0 (en) | 1989-02-09 | 1989-02-09 | Improvements in or relating to organic compounds |
| GB898902901A GB8902901D0 (en) | 1989-02-09 | 1989-02-09 | Improvements in or relating to organic compounds |
| GB898903147A GB8903147D0 (en) | 1989-02-13 | 1989-02-13 | Improvements in or relating to organic compounds |
| GB898903663A GB8903663D0 (en) | 1989-02-17 | 1989-02-17 | Improvements in or relating to organic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GR900100076A GR900100076A (en) | 1991-06-28 |
| GR1000466B true GR1000466B (en) | 1992-07-30 |
Family
ID=27516885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR900100076A GR1000466B (en) | 1989-01-28 | 1990-02-07 | Preparation method of novel pharmaceutical forms of cyclosporine |
Country Status (1)
| Country | Link |
|---|---|
| GR (1) | GR1000466B (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI65914C (en) * | 1978-03-07 | 1984-08-10 | Sandoz Ag | FRAMEWORK FOR PHARMACEUTICAL COMPOSITION OF CYCLOSPORINE A |
| NL8600050A (en) * | 1986-01-13 | 1987-08-03 | Sanico Nv | PHARMACEUTICAL PREPARATION WITH DELAYED DELIVERY OF THE ACTIVE SUBSTANCE AND METHOD FOR PREPARING IT. |
| HU205010B (en) * | 1987-09-15 | 1992-03-30 | Sandoz Ag | Process for producing pharmaceutical compositions comprising compounds soluble up to 1 per cent and having medical activity |
| KR0148748B1 (en) * | 1988-09-16 | 1998-08-17 | 장 크라메르, 한스 루돌프 하우스 | A multiphase cyclosporin composition |
-
1990
- 1990-02-07 GR GR900100076A patent/GR1000466B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GR900100076A (en) | 1991-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9000441D0 (en) | NOVEL CYCLOSPORIN GALENIC FORMS | |
| DK0553298T3 (en) | Aerosol formulation comprising beclomethasone 17,21 dipropionate | |
| DE69231991T2 (en) | Chlorofluorocarbon free aerosol formulations | |
| IT1281337B1 (en) | ORAL PHARMACEUTICAL PREPARATION CONTAINING CYCLOSPORIN AS AN ACTIVE SUBSTANCE AND A PRE-CONCENTRATED MULTIPLE EMULSION | |
| FI945619A0 (en) | Cyclosporin-containing liquid preparations and process for their preparation | |
| NL182731C (en) | COPOLYTHER ESTER PREPARATION DERIVED FROM TERPHALIC ACID OR AN ESTER-FORMING EQUIVALENT, 1.4-BUTANE DIOL, POLY (PROPYLENE OXIDE) GLYCOL AND BRANCHING AGENT. | |
| DE69425671T2 (en) | GLUCOSAMINE DISACCHARID, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS THEREOF AND THEIR USE | |
| ATE216590T1 (en) | DRUG FORMULATIONS FOR IL-12 | |
| EP0221041A3 (en) | Benzimidazole derivatives, process for their preparation and their pharmaceutical use | |
| HUT54144A (en) | Process for producing 3-desmethylmevalonic acid derivatives and pharmaceutical compositions comprising same as active ingredient | |
| SE7900685L (en) | 9-DEOXI-9A METHYLENISOSTERS OF PGIŸ2 AND PROCEDURES FOR THE PREPARATION OF THEM | |
| DE3783356T2 (en) | BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME. | |
| HUP9802861A2 (en) | Use of calendula glycosides for the treatment of psoriasis | |
| FI954986A (en) | Novel oral pharmaceutical preparations containing cyclosporine | |
| HUP9801052A2 (en) | Oral cyclosporin formulations | |
| HUT51221A (en) | Process for producing pharmaceutical compositions comprising 3-demethyl-4-fluoromevalonic acid derivatives and the active ingredients | |
| GR1000466B (en) | Preparation method of novel pharmaceutical forms of cyclosporine | |
| ATE1901T1 (en) | GUAIACOL ESTER OF ALPHA- AND BETAMERCAPTOPROPIONYLALANINE AND ALPHA- AND BETAMERCAPTOPROPIONYL-GLYCINE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| HUT46846A (en) | Process for producing pharmaceutical compositions of cardiac activity | |
| IT1204778B (en) | INJECTABLE PHARMACEUTICAL FORMULATIONS OF ACTIVE INGREDIENTS FOR GENERAL ANESTHETIC ACTIVITIES | |
| DE69116423D1 (en) | 3'-Deamino-4'-deoxy-4'-amino-8-fluoroanthracyclins and process for their preparation | |
| EP0348664A3 (en) | Pharmaceutical compositions containing monoacetoacetins for treating tumours | |
| UA26267C2 (en) | PHARMACEUTICAL OINTMENT WHICH DOES NOT EXPRESS IMPACT TO THE SKIN | |
| IT1100372B (en) | ASSOCIATION OF ANTIBIOTICS CHARACTERIZED BY DECREASED TOXICITY, AND RELATIVE PHARMACEUTICAL COMPOSITIONS | |
| TH15661A (en) | Heterocyclic compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MA | Right expired |